Affinity Enrichment and Functional Characterization of TRAX1, a Novel Transcription Activator and X1-Sequence-Binding Protein of HLA-DRA
Open Access
- 1 January 1995
- journal article
- research article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 15 (1) , 282-289
- https://doi.org/10.1128/mcb.15.1.282
Abstract
The promoters of all class II major histocompatibility (MHC) genes contain a positive regulatory motif, the X element. The DNA-binding proteins specific for this element are presumed to play a critical role in gene expression, although there is a paucity of functional studies supporting this role. In this study, the X-box-binding proteins of HLA-DRA were affinity purified from HeLa nuclear extracts. Fractions 46 to 48 contained an X-box-binding activity and were determined by electrophoretic mobility shift assays to be specific for the X1 element. This X1 sequence-binding-protein, transcriptional activator X1 (TRAX1), was shown to be a specific transcriptional activator of the HLA-DRA promoter in an in vitro transcription assay. By UV cross-linking analysis, the approximate molecular mass of TRAX1 including the bound DNA was determined to be 40 kDa. When the TRAX1 complex was incubated with antibodies against a known recombinant X-box-binding protein, RFX1, and tested in electrophoretic mobility shift assays, TRAX1 was neither shifted nor blocked by the antibody. Further analysis with methylation interference showed that TRAX1 bound to the 5' end of the X1 sequence at -109 and -108 and created hypersensitive sites at -114, -113, and -97. This methylation interference pattern is distinct from those of the known X1-binding proteins RFX1, RFX, NF-Xc, and NF-X. Taken together, our results indicate that TRAX1 is a novel X1-sequence-binding protein and transcription activator of HLA-DRA.Keywords
This publication has 82 references indexed in Scilit:
- Molecular analysis of G1B and G3A IFNγ mutants reveals that defects in CIITA or RFX result in defective class II MHC and li gene inductionImmunity, 1994
- Regulation of MHC Class II Expression by Interferon-γ Mediated by the Transactivator Gene CIITAScience, 1994
- YB-1 DNA-binding protein represses interferon gamma activation of class II major histocompatibility complex genes.The Journal of Experimental Medicine, 1994
- Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1Nature, 1993
- Nucleosome displacement in transcriptionCell, 1993
- Sequences and Factors: A Guide to MHC Class-II TranscriptionAnnual Review of Immunology, 1992
- The T-cell repertoire for antigen and MHCImmunology Today, 1988
- Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREBNature, 1988
- Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-XCell, 1988
- T cell tolerance by clonal elimination in the thymusCell, 1987